Mathias B. Møllerhøj

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH

J. Jelsing, N. Vrang, Andre Broermann, 2022, Clinical and translational science.

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

J. Jelsing, T. Vilsbøll, F. Knop, 2022, PloS one.

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

M. Vyberg, M. Feigh, Jacob Nøhr-Meldgaard, 2023, Scientific reports.